Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
Hutchison Medipharma Limited
Arvind Dasari; Sara Lonardi; Rocio Garcia-Carbonero; Elena Elez; Takayuki Yoshino; Alberto Sobrero; James Yao; Pilar García-Alfonso; Judit Kocsis; Antonio Cubillo Gracian; Andrea Sartore-Bianchi; Taroh Satoh; Violaine Randrian; Jiri Tomasek; Geoff Chong; Andrew Scott Paulson; Toshiki Masuishi; Jeremy Jones; Tibor Csőszi; Chiara Cremolini; Francois Ghiringhelli; Ardaman Shergill; Howard S Hochster; John Krauss; Ali Bassam; Michel Ducreux; Anneli Elme; Laurence Faugeras; Stefan Kasper; Eric Van Cutsem; Dirk Arnold; Shivani Nanda; Zhao Yang; William R Schelman; Marek Kania; Josep Tabernero; Cathy Eng; FRESCO-2 Study Investigators